PMID- 22490269
OWN - NLM
STAT- MEDLINE
DCOM- 20120806
LR  - 20211021
IS  - 1749-8090 (Electronic)
IS  - 1749-8090 (Linking)
VI  - 7
DP  - 2012 Apr 10
TI  - Surgical treatment of tricuspid regurgitation after mitral valve surgery: a 
      retrospective study in China.
PG  - 30
LID - 10.1186/1749-8090-7-30 [doi]
AB  - BACKGROUND: Functional tricuspid regurgitation (TR) occurs in patients with 
      rheumatic mitral valve disease even after mitral valve surgery. The aim of this 
      study was to analyze surgical results of TR after previous successful mitral 
      valve surgery. METHODS: From September 1996 to September 2008, 45 patients with 
      TR after previous mitral valve replacement underwent second operation for TR. In 
      those, 43 patients (95.6%) had right heart failure symptoms (edema of lower 
      extremities, ascites, hepatic congestion, etc.) and 40 patients (88.9%) had 
      atrial fibrillation. Twenty-six patients (57.8%) were in New York Heart 
      Association (NYHA) functional class III, and 19 (42.2%) in class IV. Previous 
      operations included: 41 for mechanical mitral valve replacement (91.1%), 4 for 
      bioprosthetic mitral valve replacement (8.9%), and 7 for tricuspid annuloplasty 
      (15.6%). RESULTS: The tricuspid valves were repaired with Kay's (7 cases, 15.6%) 
      or De Vega technique (4 cases, 8.9%). Tricuspid valve replacement was performed 
      in 34 cases (75.6%). One patient (2.2%) died. Postoperative low cardiac output 
      (LCO) occurred in 5 patients and treated successfully. Postoperative 
      echocardiography showed obvious reduction of right atrium and ventricle. The 
      anterioposterior diameter of the right ventricle decreased to 25.5 +/- 7.1 mm from 
      33.7 +/- 6.2 mm preoperatively (P < 0. 05). CONCLUSION: TR after mitral valve 
      replacement in rheumatic heart disease is a serious clinical problem. If it 
      occurs or progresses late after mitral valve surgery, tricuspid valve 
      annuloplasty or replacement may be performed with satisfactory results. Due to 
      the serious consequence of untreated TR, aggressive treatment of existing TR 
      during mitral valve surgery is recommended.
FAU - Li, Zong-Xiao
AU  - Li ZX
AD  - Department of Cardiovascular Surgery, TEDA International Cardiovascular Hospital, 
      Medical College, Nankai University, Tianjin, China.
FAU - Guo, Zhi-Peng
AU  - Guo ZP
FAU - Liu, Xiao-Cheng
AU  - Liu XC
FAU - Kong, Xiang-Rong
AU  - Kong XR
FAU - Jing, Wen-Bin
AU  - Jing WB
FAU - Chen, Tie-Nan
AU  - Chen TN
FAU - Lu, Wan-Li
AU  - Lu WL
FAU - He, Guo-Wei
AU  - He GW
LA  - eng
PT  - Evaluation Study
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20120410
PL  - England
TA  - J Cardiothorac Surg
JT  - Journal of cardiothoracic surgery
JID - 101265113
SB  - IM
MH  - Adult
MH  - Aged
MH  - *Cardiac Valve Annuloplasty
MH  - China
MH  - Female
MH  - Follow-Up Studies
MH  - *Heart Valve Prosthesis Implantation/mortality
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Mitral Valve Insufficiency/*surgery
MH  - Mitral Valve Stenosis/*surgery
MH  - Retrospective Studies
MH  - Rheumatic Heart Disease/*surgery
MH  - Treatment Outcome
MH  - Tricuspid Valve Insufficiency/mortality/*surgery
PMC - PMC3348082
EDAT- 2012/04/12 06:00
MHDA- 2012/08/07 06:00
PMCR- 2012/04/10
CRDT- 2012/04/12 06:00
PHST- 2012/01/12 00:00 [received]
PHST- 2012/04/10 00:00 [accepted]
PHST- 2012/04/12 06:00 [entrez]
PHST- 2012/04/12 06:00 [pubmed]
PHST- 2012/08/07 06:00 [medline]
PHST- 2012/04/10 00:00 [pmc-release]
AID - 1749-8090-7-30 [pii]
AID - 10.1186/1749-8090-7-30 [doi]
PST - epublish
SO  - J Cardiothorac Surg. 2012 Apr 10;7:30. doi: 10.1186/1749-8090-7-30.